BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10630522)

  • 1. Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients.
    Blank BS; Meenhorst PL; Weverling GJ; Stout-Zonneveld AA; Pauw W; Mulder JW; van Dijk WC; Smits P; Lange JM
    AIDS; 1999 Dec; 13(18):2533-9. PubMed ID: 10630522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
    Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
    J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
    Reynes J; Montes B; Atoui N; Segondy M
    J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia.
    Sénéchal M; Dorent R; du Montcel ST; Fillet AM; Ghossoub JJ; Dubois M; Pavie A; Gandjbakhch I
    Clin Transplant; 2003 Oct; 17(5):423-7. PubMed ID: 14703924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
    Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
    Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between human cytomegalovirus quantitative p72 antigenemia and viremia.
    Reina J; Blanco I; Munar M
    Clin Diagn Virol; 1996 Oct; 7(1):63-7. PubMed ID: 9077431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.
    Torrús D; Portilla J; Hernández-Aguado I; Boix V; Plazas J; Gimeno A; Torromé M; Llopis C; Valls V; Sánchez-Payá J
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):630-5. PubMed ID: 10534184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients.
    Cariani E; Pollara CP; Valloncini B; Perandin F; Bonfanti C; Manca N
    BMC Infect Dis; 2007 Nov; 7():138. PubMed ID: 18036216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
    AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.
    Blank BS; Meenhorst PL; Mulder JW; Weverling GJ; Putter H; Pauw W; van Dijk WC; Smits P; Lie-A-Ling S; Reiss P; Lange JM
    J Clin Microbiol; 2000 Feb; 38(2):563-9. PubMed ID: 10655346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
    Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
    Boeckh M; Gallez-Hawkins GM; Myerson D; Zaia JA; Bowden RA
    Transplantation; 1997 Jul; 64(1):108-13. PubMed ID: 9233710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial.
    Gerna G; Lilleri D; Baldanti F; Torsellini M; Giorgiani G; Zecca M; De Stefano P; Middeldorp J; Locatelli F; Revello MG
    Blood; 2003 Jun; 101(12):5053-60. PubMed ID: 12586622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up.
    Bek B; Boeckh M; Lepenies J; Bieniek B; Arasteh K; Heise W; Deppermann KM; Bornhöft G; Stöffler-Meilicke M; Schuller I; Höffken G
    J Clin Microbiol; 1996 Feb; 34(2):457-9. PubMed ID: 8789039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients.
    Podzamczer D; Ferrer E; García A; Ramón JM; Niubó J; Santín M; Rufí G; Pérez JL; Martín R; Gudiol F
    Scand J Infect Dis; 1997; 29(3):223-7. PubMed ID: 9255879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
    Zhang C; Shen K; Jiang Z; He X
    Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presence of circulating cytomegalic cells in HIV negative immunosuppressed individuals following cytomegalovirus infection].
    Castaño ME; Sarmiento M; Vélez L; González JC; Cuéllar F; Rugeles MT; Bedoya VI
    Biomedica; 2005 Mar; 25(1):129-35. PubMed ID: 15962909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.